Preliminary probe suggests that viral Hepatitis and a possible water contamination were behind the deaths, however, a ...
In 1991, the CDC’s Advisory Committee on Immunization Practices (ACIP) recommended hepatitis B vaccination at birth for all ...
According to one analyst, the alliance and early data “validate” the oncology work of Vir, which was once purely an ...
DelveInsight's Chronic Hepatitis D Market Insights report includes a comprehensive understanding of current treatment practices, chronic hepatitis D emerging drugs, market share of individual ...
Stocktwits on MSN
VIR stock surges 60% pre-market today – analysts cheer strong cancer data, Astellas partnership
McCutcheon said findings presented for VIR-5500 surpassed expectations and strengthened Vir’s standing among therapies in ...
The chronic hepatitis D virus market is expected to grow steadily, driven by a relatively small pipeline of emerging therapies. Leading candidates, such as Brelovitug from Bluejay Therapeutics and the ...
The presentations can be found on the Posters & Presentations section of the Aligos website ( www.aligos.com) after the live event.
Huahui Health has won the first approval in China for a drug to treat chronic infections with hepatitis D virus (HDV), plugging a major gap in treatment options. China's National Medical Products ...
BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for chronic ...
BEIJING, Jan. 27, 2026 /PRNewswire/ -- Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results